Telomerase activity is a biomarker for high grade malignant peripheral nerve sheath tumors in neurofibromatosis type I individuals

Genes Chromosomes and Cancer

Volumn 47, Issue 3, 2008, Pages 238-246

  Mantripragada, Kiran K ^a   Caley, Matthew ^a   Stephens, Phil ^a   Jones, Christopher J ^a   Kluwe, Lan ^b   Guha, Abhijit ^c   Mautner, Victor ^b   Upadhyaya, Meena ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ISOENZYME; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; DERMAL NEUROFIBROMA; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; NERVE SHEATH TUMOR; NEUROFIBROMATOSIS; PERIPHERAL NERVE; PLEXIFORM NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

BIOLOGICAL MARKERS; HUMANS; NERVE SHEATH NEOPLASMS; NEUROFIBROMA; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMATOSIS 1; RNA; SEVERITY OF ILLNESS INDEX; TELOMERASE;

EID: 38549145802     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20525     Document Type: Article

References (55)

1. Aogi K, Woodman A, Urquidi V, Mangham DC, Tarin D, Goodison S. 2000. Telomerase activity in soft-tissue and bone sarcomas. Clin Cancer Res 6:4776-4781.
2. Avilion AA, Pia yszck MA, Gupta J, Shay JW, Bacchetti S, Greider CW. 1996. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650.
3. Blackburn EH. 1991. Structure and function of telomeres. Nature 350:569-573.
4. Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB, Bacchetti S. 1992. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. Embo J 11:1921-1929.
5. Dome JS, Look AT. 1999. Three molecular determinants of malignant conversion and their potential as therapeutic targets. Curr Opin Oncol 11:58-67.
6. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A. 2002. Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311-314.
7. Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP, Adams RR, Chang E, Allsopp RC, Yu J. 1995. The RNA component of human telomerase. Science 269:1236-1241.
8. Ferner RE. 2007. Neurofibromatosis 1. Eur J Hum Genet 15:131-138.
9. Greider CW. 1990. Telomeres, telomerase and senescence. Bioessays 12:363-369.
10. Greider CW. 1998. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95:90-92.
11. Gunther T, Schneider-Stock R, Hackel C, Pross M, Schulz HU, Lippert H, Roessner A. 2000. Telomerase activity and expression of hTRT and hTR in gastrointestinal stromal tumors in comparison with extragastrointestinal sarcomas. Clin Cancer Res 6:1811-1818.
12. Hagel C, Zils U, Peiper M, Kluwe L, Gotthard S, Friedrich RE, Zurakowski D, von Deimling A, Mautner VF. 2007. Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors. J Neurooncol 82:187-192.
13. Hiyama E, Hiyama K. 2003. Telomerase as tumor marker. Cancer Lett 194:221-233.
14. Hiyama E, Hiyama K. 2007. Telomere and telomerase in stem cells. Br J Cancer 96:1020-1024.
15. Hiyama E, Hiyama K, Yokoyama T, Shay JW. 2001. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3:17-26.
16. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M. 1995. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155:3711-3715.
17. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW, Wright WE, White MA. 1999. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev 13:817-826.
18. Janknecht R. 2004. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett 564:9-13.
19. Kanaya T, Kyo S, Takakura M, Ito H, Namiki M, Inoue M. 1998. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int J Cancer 78:539-543.
20. Karube K, Nabeshima K, Ishiguro M, Harada M, Iwasaki H. 2006. cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours. J Clin Pathol 59:160-165.
21. Keith WN, Bilsland A, Evans TR, Glasspool RM. 2002. Telomerase-directed molecular therapeutics. Expert Rev Mol Med 22:1-25.
22. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. 1997. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019.
23. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW. 1994. Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
24. Kleideiter E, Schwab M, Friedrich U, Koscielniak E, Schafer BW, Klotz U. 2003. Telomerase activity in cell lines of pediatric soft tissue sarcomas. Pediatr Res 54:718-723.
25. Kuniyasu H, Domen T, Hamamoto T, Yokozaki H, Yasui W, Tahara H, Tahara E. 1997. Expression of human telomerase RNA is an early event of stomach carcinogenesis. Jpn J Cancer Res 88:103-107.
26. Kyo S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, Inoue M. 1999. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 80:804-809.
27. Levy P, Vidaud D, Leroy K, Laurendeau I, Wechsler J, Bolasco G, Parfait B, Wolkenstein P, Vidaud M, Bieche I. 2004. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Mol Cancer 3:20.
28. Li H, Zhao L, Yang Z, Founder JW, Liu JP. 1998. Telomerase is controlled by protein kinase Cα in human breast cancer cells. J Biol Chem 273:33436-33442.
29. Li H, Zhao LL, Funder JW, Liu JP. 1997. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J Biol Chem 272:16729-16732.
30. Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO, Harrington L. 2000. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 10:1459-1462.
31. Meeker AK, Coffey DS. 1997. Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. Biochemistry (Moscow) 62:1323-1331.
32. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. 1997. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795.
33. Miller SJ, Rangwala F, Williams J, Ackerman P, Kong S, Jegga AG, Kaiser S, Aronow BJ, Frahm S, Kluwe L, Mautner V, Upadhyaya M, Muir D, Wallace M, Hagen J, Quelle DE, Watson MA, Perry A, Gutmann DH, Ratner N. 2006. Large-scale molecular comparison of human schwann cells to malignant peripheral nerve sheath tumor cell lines and tissues. Cancer Res 66:2584-2591.
34. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR. 1997. Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959.
35. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. 1997. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res 231:346-353.
36. Rohde V, Sattler HP, Bund T, Bonkhoff H, Fixemer T, Bachmann C, Lensch R, Unteregger G, Stoeckle M, Wullich B. 2000. Expression of the human telomerase reverse transcriptase is not related to telomerase activity in normal and malignant renal tissue. Clin Cancer Res 6:4803-4809.
37. Schneider-Stock R, Epplen C, Radig K, Oda Y, Dralle H, Hoang-Vu C, Epplen JT, Roessner A. 1998a. On telomere shortening in soft-tissue tumors. J Cancer Res Clin Oncol 124:165-171.
38. Schneider-Stock R, Eppler C, Walter H, Radig K, Haeckel C, Hoang-Vu C, Epplen JT, Roessner A. 1998b. Telomere lengths and telomerase activity in liposarcomas. Verh Dtsch Ges Pathol 82:226-231.
39. Schneider-Stock R, Jaeger V, Rys J, Epplen JT, Roessner A. 2000. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/round-cell liposarcomas. Int J Cancer 89:63-68.
40. Shay JW, Bacchetti S. 1997. A survey of telomerase activity in human cancer. Eur J Cancer 33:787-791.
41. Soder AI, Hoare SF, Muir S, Going JJ, Parkinson EK, Keith WN. 1997. Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14:1013-1021.
42. Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Tahara E, Ide T. 1999. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 18:1561-1567.
43. Takakura M, Kyo S, Kanaya T, Tanaka M, Inoue M. 1998. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res 58:1558-1561.
44. Terasaki T, Kyo S, Takakura M, Maida Y, Tsuchiya H, Tomita K, Inoue M. 2004. Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Oncol Rep 11:1307-1311.
45. Tomoda R, Seto M, Tsumuki H, Iida K, Yamazaki T, Sonoda J, Matsumine A, Uchida A. 2002. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer 95:1127-1133.
46. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR. 1998. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168-4172.
47. Ulaner GA, Hu JF, Vu TH, Oruganti H, Giudice LC, Hoffman AR. 2000. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 85:330-335.
48. Umehara N, Ozaki T, Sugihara S, Kunisada T, Morimoto Y, Kawai A, Nishida K, Yoshida A, Murakami T, Inoue H. 2004. Influence of telomerase activity on bone and soft tissue tumors. J Cancer Res Clin Oncol 130:411-416.
49. Watson MA, Perry A, Tihan T, Prayson RA, Guha A, Bridge J, Ferner R, Gutmann DH. 2004. Gene expression profiling reveals unique molecular subtypes of neurofibromatosis Type I-associated and sporadic malignant peripheral nerve sheath tumors. Brain Pathol 14:297-303.
50. Weiss SW, Goldblum JR. 2001 Malignant tumors of the peripheral nerves. In: Enzinger, Weiss, editors. Soft Tissue Tumors. St. Louis: Mosby. pp. 1209-1263.
51. Woodruff JM, Kourea HP, Louis DN, Scheithauer BW. 2000. Malignant nerve sheath tumor (MPNST). In: Kleihues P, Cavenee WK, editors. Pathology and Genetics of Tumours of the Nervous System. Lyon, France: IARC Press. pp. 172-174.
52. Yan P, Benhattar J, Coindre JM, Guillou L. 2002. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Int J Cancer 98:851-856.
53. Yan P, Coindre JM, Benhattar J, Bosman FT, Guillou L. 1999. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res 59:3166-3170.
54. Yashima K, Piatyszek MA, Saboorian HM, Vitmani AK, Brown D, Shay JW, Gazdar AF. 1997. Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 50:110-117.
55. Zakian VA. 1989. Structure and function of telomeres. Annu Rev Genet 23:579-604.